DIVINHEALSimplifying Global Wellbeing
Home
Treatments
Hospitals
Doctors
Page background

About

Immunotherapy & CAR-T Cell Therapy in New Delhi for Bangladesh Patients

For many patients in Bangladesh facing complex cancer diagnoses, the prospect of advanced treatments like Immunotherapy or CAR-T Cell Therapy can bring a mix of hope and significant concern. The availability, expertise, and comprehensive care required for such sophisticated procedures often lead families to explore options beyond their home country.

Patients seeking cutting-edge solutions increasingly look towards New Delhi. The city has emerged as a key medical hub, offering an environment where specialized cancer care is both accessible and highly coordinated. This focus allows for dedicated attention to intricate treatment plans and patient needs.

New Delhi's medical infrastructure includes numerous JCI-accredited hospitals and renowned oncology specialists who are proficient in these advanced therapies. The commitment to maintaining international medical standards within the city's hospitals provides a reliable setting for patients seeking long-term care and follow-up.

New Delhi provides a comprehensive and trustworthy destination for specialized cancer treatments.

What is Immunotherapy & CAR-T Cell Therapy?

Immunotherapy is a revolutionary cancer treatment that harnesses the body's own immune system to fight cancer cells. Instead of directly attacking cancer, it stimulates the immune system to recognize and destroy malignant cells. CAR-T Cell Therapy is a highly specialized form of immunotherapy where a patient's T-cells (a type of immune cell) are collected, genetically engineered in a lab to produce chimeric antigen receptors (CARs), and then reinfused into the patient. These modified CAR T-cells are specifically designed to find and eliminate cancer cells expressing a particular antigen, offering a targeted and potent attack against certain types of blood cancers and solid tumors.

Exploring Immunotherapy and CAR-T Cell Therapy Options

Immunotherapy encompasses several approaches:

  • Checkpoint Inhibitors: Medications that block proteins (checkpoints) on immune cells or cancer cells, releasing the brakes on the immune system.
  • T-Cell Transfer Therapy: Enhancing the natural ability of T-cells to fight cancer, which includes CAR-T cell therapy.
  • Monoclonal Antibodies: Lab-produced antibodies that can target specific markers on cancer cells or immune cells.
  • Oncolytic Viruses: Viruses engineered to infect and destroy cancer cells while sparing healthy tissue.
  • Cancer Vaccines: Stimulating the immune system to recognize and attack cancer cells.

CAR-T Cell Therapy is a distinct T-cell transfer method, primarily targeting:

  • B-cell acute lymphoblastic leukemia (ALL)
  • Diffuse large B-cell lymphoma (DLBCL)
  • Mantle cell lymphoma (MCL)
  • Follicular lymphoma (FL)
  • Multiple myeloma

When Is This Treatment Option Considered?

  • When conventional treatments like chemotherapy or radiation have been ineffective.
  • For specific types of blood cancers, such as certain lymphomas, leukemias, and multiple myeloma.
  • In cases of metastatic cancer where the disease has spread to other parts of the body.
  • For patients whose cancer cells express specific targets that immunotherapy or CAR-T cells can recognize.
  • When there are limited other treatment options available for the patient's cancer type.

What Pre-Treatment Evaluation Is Necessary?

  • Comprehensive physical examination and medical history review.
  • Advanced imaging scans such as PET-CT, MRI, or CT scans to assess tumor burden and spread.
  • Biopsy of the tumor or bone marrow to confirm diagnosis, stage the cancer, and identify specific biomarkers.
  • Blood tests including complete blood count, kidney function, liver function, and viral screenings.
  • Cardiac and pulmonary function tests to ensure the patient can tolerate the treatment.
  • Genetic and molecular profiling of cancer cells to determine suitability for targeted therapies.

How Is Immunotherapy and CAR-T Cell Therapy Performed?

The exact procedure for Immunotherapy and CAR-T Cell Therapy is tailored to the individual patient, their specific cancer type, and overall health.

Immunotherapy General Steps:

Immunotherapy usually involves intravenous infusions of drugs on an outpatient basis over several weeks or months. The specific drug, dosage, and frequency depend on the type of immunotherapy, the cancer type, and the patient’s response. Regular monitoring is crucial to manage potential side effects and assess treatment effectiveness.

CAR-T Cell Therapy Specific Steps:

  1. Cell Collection (Apheresis): Blood is drawn from the patient, and a specialized machine separates and collects T-cells while returning other blood components. This usually takes a few hours.
  2. Cell Engineering: The collected T-cells are sent to a specialized laboratory where they are genetically modified to express CARs on their surface. This process typically takes several weeks.
  3. Expansion: The modified CAR T-cells are then grown and multiplied in the lab to create millions of these cancer-fighting cells.
  4. Conditioning Chemotherapy: Before CAR T-cell infusion, the patient often receives a short course of chemotherapy to reduce existing immune cells, creating space for the new CAR T-cells to expand.
  5. Infusion: The engineered CAR T-cells are infused back into the patient intravenously, similar to a blood transfusion. This is usually done in a specialized inpatient setting.
  6. Monitoring: Patients are closely monitored in the hospital for several weeks post-infusion for potential severe side effects like Cytokine Release Syndrome (CRS) and neurotoxicity.

Connect with leading oncologists in New Delhi for personalized treatment plans.

Get a Free Expert Opinion Today

Understanding the Recovery Process

Recovery from Immunotherapy and especially CAR-T Cell Therapy requires careful management and can vary greatly. For general immunotherapy, patients might experience fatigue, skin reactions, or gastrointestinal issues, which are managed with supportive care. For CAR-T Cell Therapy, the initial recovery period in the hospital typically lasts several weeks due to the risk of significant side effects like Cytokine Release Syndrome (CRS) and neurotoxicity. Patients require close monitoring by a specialized medical team. After discharge, continued outpatient follow-up is essential to track progress, manage late-onset side effects, and monitor for any signs of recurrence. Long-term follow-up can extend for years, including regular check-ups, blood tests, and scans. Rehabilitation, often involving nutritional support and physical therapy, helps patients regain strength and quality of life.

Potential Risks and Expected Success Rates

  • Early Risks (Immunotherapy): Fatigue, skin rash, diarrhea, thyroid dysfunction, and inflammation in various organs (colitis, pneumonitis, hepatitis).
  • Late Risks (Immunotherapy): Autoimmune side effects can persist or emerge months after treatment, requiring ongoing monitoring and management.
  • Early Risks (CAR-T Cell Therapy): Cytokine Release Syndrome (CRS) with fever, low blood pressure, difficulty breathing; Immune effector Cell-Associated Neurotoxicity Syndrome (ICANS) causing confusion, seizures, or speech difficulties.
  • Late Risks (CAR-T Cell Therapy): Prolonged low blood counts (cytopenias), increased risk of infection, and potential for secondary malignancies or hypogammaglobulinemia.

The success rates for Immunotherapy and CAR-T Cell Therapy are highly variable, depending on the type of cancer, its stage, previous treatments, and individual patient factors. While these therapies have shown remarkable outcomes in specific advanced cancers, leading to long-term remissions for some, they are not universally effective. Immunotherapy can achieve durable responses in a significant minority of patients for various solid tumors. CAR-T Cell Therapy, particularly, has shown high remission rates in certain refractory blood cancers, but not all patients respond, and some may relapse. Long-term outcomes are still being studied, but for many, these treatments offer a new lease on life where other options have failed.

Cost of Immunotherapy & CAR-T Cell Therapy in New Delhi

The cost of advanced cancer treatments like Immunotherapy and CAR-T Cell Therapy in New Delhi is influenced by several factors. These include the specific type of therapy chosen, the duration and number of cycles required, the hospital's reputation and facilities, the experience level of the treating specialists, and any additional supportive care needed throughout the treatment journey.

A broad estimate for Immunotherapy and CAR-T Cell Therapy in New Delhi can range significantly due to the therapy's complexity and personalized nature.

New Delhi vs. Global Cost Comparison for Advanced Cancer Therapies

Patients from Bangladesh often find New Delhi's medical costs substantially more affordable compared to Western countries, without compromising on quality of care. This makes New Delhi a highly attractive option for specialized treatments.

Location Estimated Cost Range (USD)
New Delhi, India $50,000 - $150,000
United States $300,000 - $700,000+
United Kingdom $200,000 - $500,000
Germany $180,000 - $450,000
Singapore $150,000 - $400,000

Support Services for Your Treatment Journey in New Delhi

  • Personalized medical guidance and treatment plan development with top oncologists.
  • Assistance with hospital appointments, admission procedures, and language translation.
  • Support for visa application processes and local travel arrangements within New Delhi.
  • Coordination of accommodation options near the hospital for patients and their families.
  • Access to dedicated patient care managers for ongoing support and information.
  • Guidance on post-treatment follow-up and rehabilitation services.

Essential Papers Required for Your Medical Visit to New Delhi

  • A valid passport and Indian medical visa.
  • Comprehensive medical reports, diagnostic scans, and biopsy results in English.
  • Referral letters from your primary physician or oncologist in Bangladesh.
  • Details of any previous treatments, medications, or allergies.
  • Proof of financial solvency for treatment costs and stay.
  • Contact information for emergency contacts both in Bangladesh and New Delhi.

Preparing for Your Procedure in New Delhi

  • Complete all recommended pre-treatment evaluations and tests as advised by the New Delhi medical team.
  • Ensure all necessary documents and medical records are organized and accessible.
  • Discuss potential treatment side effects and recovery expectations with your medical team.
  • Arrange for a companion or family member to accompany you for support during your stay.
  • Understand the financial aspects, including estimated costs and payment methods, before arrival.
  • Follow any specific dietary or medication instructions provided by your doctor prior to admission.

Recovery and Follow-Up Care After Treatment

  • Adhere strictly to all prescribed medications and follow-up schedules.
  • Monitor for any new symptoms or side effects and report them immediately to your care team.
  • Engage in gentle physical activity as advised to aid in regaining strength.
  • Maintain a nutritious diet and adequate hydration to support healing.
  • Attend all scheduled post-treatment check-ups and diagnostic tests.
  • Consider mental health support or counseling if needed during recovery.

Ready to explore advanced cancer care? We are here to guide you every step of the way.

Contact Us for a Consultation

Take the Next Step Towards Better Health

Navigating complex cancer treatments can be challenging, but with the right guidance and support, a path to recovery is within reach in New Delhi.

Hospitals Offering this treatment

India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.

Meet Our Doctors

Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.

Dr. Shelly Mittal

Dr. Shelly Mittal

Sr. Consultant

Medical Oncology & Hematology

New Delhi

14+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Hari Goyal

Dr. Hari Goyal

Director

Medical Oncology & Haemato-Oncology

New Delhi

34+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details

Related Links

هل أنت مستعد لبدء رحلتك العلاجية؟

احصل على خيارات علاجية شخصية من أفضل مستشفيات الهند. خبراؤنا الطبيون جاهزون لمساعدتك في كل خطوة.